Navigation Links
Heritage Announces $10 Million Financing
Date:4/15/2008

LONDON and EDISON, N.J., April 15 /PRNewswire/ -- Heritage Pharma Ltd. (U.K.) and its wholly owned subsidiary, Heritage Pharmaceuticals Inc. (collectively "Heritage"), announced today the Company has consummated the private placement of Series A Preferred shares lead by Oklahoma City, Oklahoma-based venture capital investors McClendon Venture Company, LLC and TLW Venture Company, LLC for gross proceeds of $10 million prior to fees and expenses. The proceeds will be utilized to finance North America and India product development costs, to establish a research and development facility and for other general corporate purposes.

Commenting on the agreement, Heritage President & CEO, Jeffrey Glazer, stated, "We are very excited to complete this new round of financing. The Company is at a turning point and the infusion of capital will enable us to execute additional global growth strategies that will take Heritage to the next level. Establishment of our own R&D center will provide Heritage with an added level of integration in order to continue growing our generic product pipeline and commercial portfolio. We look forward to adding new product launches this year from our existing portfolio while accelerating our future growth."

About Heritage

Heritage Pharmaceuticals Inc. is a rapidly emerging generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Heritage has established itself as a competitor in the generic pharmaceutical industry by initially targeting niche products with revenues that are generally too small to command the resources and attention of major market participants. Heritage launched its U.S. label in 2006 and currently markets 5 products over 17 SKU's, including Ethambutol oral tablets, Hydralazine oral tablets, Hydrochlorothiazide oral tablets, Sulindac oral tablets and Nimodipine soft gel caps
'/>"/>

SOURCE Heritage Pharma Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Heritage Victor Valley Medical Group to Host Youth Soccer Clinic
2. UPMC Health Plan and Heritage Valley Health System Combine Resources in LifeSmart, A Community Initiative Designed to Prevent Diabetes
3. Dr. Richard Merkin & Heritage Victor Valley Medical Group to Host Victorville Senior Valentines Day Luncheon
4. Heritage Valley Health System Named a Finalist for Microsoft Healthcare User Group Award
5. Transition of Behavioral Health Services from WPIC-BV to Heritage Valley Health System
6. Heritage and Mission of Serving Children Reflected in Reintroduction of Boys Town Name and Look
7. Kimberly Clark Professional Skin Care Plant Celebrates 30th Anniversary and Strong Heritage of Success in San Antonio
8. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
9. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
10. NHP Announces First Quarter Earnings Release Date and Conference Call/Webcast
11. CryoLife Announces Release Date and Teleconference Call Details for First Quarter 2008 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)... , WASHINGTON, Nov. 30 - Salon L...ause" on Monday, December 7(th) to raise funds and...hood terminal diseases. All proceeds from each hai...dren,s Research Hospital. ,, Salon Leau has be... The salon is owned by LoAnn Lai, widely recognize...
(Date:11/30/2009)... , NASHVILLE, Tenn., Nov. 30 /PRNewswire...ng about gifts for the holidays. For a loved one w... family members and friends oftentimes struggle wi... Living , one of the leading providers of senior l...er,s and dementia care , offers these suggestions....
(Date:11/30/2009)... , CHICAGO, Nov. 30 Physicians...reported today on results of a study demonstrating...CT angiography (cCTA) by Rcadia,s COR Analyzer Sys... artery stenosis in hospital emergency department ... automated system to enhance the use of cCTA has p...
(Date:11/30/2009)...CAGONovember 30, 2009A pet owner knows the enormou...cially in troubled times. Most pets are considered... companions. A growing body of research now docume...velopment, elderly care, mental illness, physical ...nd the rehabilitation of incarcerated youth and ad...
(Date:11/30/2009)...se extra helpings of gravy and dessert at the holi...e than previously thought. According to a new rese...B Journal ( http://www.fasebj.org ), a diet that ...enes that ultimately cause our bodies to store too...ouble-whammy as the already difficult task of conv...
Breaking Medicine News(10 mins):Health News:Georgetown Hair Salon Helps St. Jude Find A Cure 2Health News:Gift Ideas for Loved Ones with Alzheimer's/Dementia 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 2Health News:Rcadia COR Analyzer(R) System Demonstrates Potential in Emergency Department Triage of Chest Pain Patients at Low to Moderate Risk of Coronary Artery Disease 3Health News:The therapeutic benefits of the human-animal bond 2Health News:Western diets turn on fat genes 2
...-FirstCall/ - QLT Inc. (NASDAQ: QLTI;,TSX: QLT) to...s and,portfolio review, the Board of Directors has...gned to enhance shareholder value., These initia...ology product for the treatment of acne vulga...
...unosyn,Corporation (OTC Bulletin Board: IMYN) did ...Research Profile on the company issued by Proteus,...research company, nor the,associated press release...his time., About Immunosyn Corporation, La Jolla...
...e of Australia,s largest,pharmacy groups, Chemmart...rd off the competitive threat posed by discount ch...and in the first month of,operation, participating... more than 160 Chemmart pharmacies nationwide. It ...
...ild nutrition interventions were implemented in po...ld be reduced by a third, and deaths by up to a qu...oday. , Professor Simon Cousens, of the London Sc...ich is being launched this week. Professor Cousens...
...American,HealthChoice, Inc. (Pink Sheets: AMHI), a...Texas and Tennessee, today, in an update for Compa...ended September 30, 2007,totaled $243,000., "It w...s as we move into 2008.", Dr. Stucki said:, The ...
... Universal,Health Services, Inc. (NYSE: UHS ) ann...pay a cash dividend of $0.08 per share on March 17...08., Universal Health Services, Inc. is one of th...ide and in Puerto Rico., Certain statements in th...
Other Medicine News:Health News:QLT Inc. announces initial steps in strategic restructuring 2Health News:QLT Inc. announces initial steps in strategic restructuring 3Health News:QLT Inc. announces initial steps in strategic restructuring 4Health News:Equity Research Firm Issued Unauthorized Report and Press Release on Immunosyn Corporation Today 2Health News:Chemmart(R) Sees Instant Results From Launch of New Rewards Program 2Health News:One third of stunting and a quarter of deaths among under 3s in poor countries could be prevented 2Health News:American HealthChoice CEO Dr. J.W. Stucki Provides Company Update 2Health News:American HealthChoice CEO Dr. J.W. Stucki Provides Company Update 3
(Date:11/30/2009)...SDALE, Ariz., Nov. 30 Ni...f radiology solutions to radiology groups and hosp...d a redesigned Quality Assurance (QA) program to f...iologists and customers and to deliver superior pa... overview of the new QA program in several present...
(Date:11/30/2009)... YORK, Nov. 30 Reportlinker.com an...able in its catalogue: ,, Outsourcing Opportun...http://www.reportlinker.com/p0165747/Outsourcing-O...port Description ,, Medical devices form one of...an estimated size of $250 billion in 2009 and a gr...
(Date:11/30/2009)..., N.J., Nov. 30 MedQ...technology-enabled clinical documentation services...iological Society of North America (RSNA) conferen..., the product leverages SpeechQ(TM), the company,s...ion used by thousands of radiologists. MedQuist h...
Breaking Medicine Technology:NightHawk Radiology Launches Redesigned Quality Assurance Program 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 2Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 3Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 4Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 5Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 6Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 7Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 8Reportlinker Adds Outsourcing Opportunities in the Medical Device (2009 - 2014) 9MedQuist Features SpeechQ VTB for Radiology Solution at RSNA Convention 2Prototype NIST method detects and measures elusive hazards 9838 1Prototype NIST method detects and measures elusive hazards 9838 2 24750 000 Awarded for Cutting Edge Asthma Research to See Changes in the Lungs During an Attack 56581 1 24750 000 Awarded for Cutting Edge Asthma Research to See Changes in the Lungs During an Attack 56581 2Joint Briefing on Proposed Health Care Reform 56576 1Joint Briefing on Proposed Health Care Reform 56576 2Joint Briefing on Proposed Health Care Reform 56576 3
...10 data presentations demonstrate the safety and a...ungal agent, CHICAGO, Sept. 18 New data from a p...that MYCAMINE(R) (micafungin sodium) for,injection...pitalized,patients of all ages with serious, under... studies, which represent the largest,published sa...
.../ritonavir data presented at ICAAC -, BRIDGEWATER...mized, controlled, open-label Phase 3 study showed... adults taking an investigational dose of,PREZISTA...100 mg ritonavir,once daily with TRUVADA(R)(1) (em...ched an undetectable viral load (<50 copies/mL...
Other Medicine Technology:New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile 2New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile 3New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile 4New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 2New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 3New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 4New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 5New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 6New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 7
...he new DeVilbiss PulmoAide Compact Compressor prov... portable, small size allows for therapy at home o...ranty, and the same reliable operation you have co...mpact Compressor is the perfect solution for those...
... lightweight (4.2lbs) portable unit with a unique ...res an oil free aluminum alloy integrated uni-posi.... Available in a variety of combinations with Sal...nt Carrying bag is also available. , ,The Salter...
KLEPPINGER wire-wave tongs
Tripolar® Cutting Forceps
Medicine Products: